Obsidian Therapeutics, Inc. · NASDAQ:OBX

Obsidian Therapeutics, Inc. shareholders

As of Sep 30, 2026, 58 institutions reported holding Obsidian Therapeutics, Inc., 83.7% of its shares. Largest: Ra Capital Management, L.P., Atlas Venture Life Science Advisors, LLC and Paradigm Biocapital Advisors LP. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Obsidian Therapeutics, Inc.ChangeFiled
Ra Capital Management, L.P.5.96M9.6%newNov 16, 2026
Atlas Venture Life Science Advisors, LLC4.5M7.3%newNov 10, 2026
Paradigm Biocapital Advisors LP4.16M6.7%newNov 16, 2026
Novo Holdings A/S3.12M5.1%newNov 16, 2026
Vanguard2.75M4.5%newNov 13, 2026
Trails Edge Capital Partners, LP2.5M4.0%newNov 16, 2026
Octagon Capital Advisors LP2.41M3.9%newNov 16, 2026
TCG Crossover Management, LLC2.2M3.6%newNov 16, 2026
Deep Track Capital, LP2.12M3.4%newNov 16, 2026
Citadel1.95M3.2%newNov 16, 2026

Obsidian Therapeutics, Inc. insider trades